MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 115 filers reported holding MIRATI THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,835,000 | +482.5% | 14,238 | +252.6% | 0.09% | +468.8% |
| Q3 2019 | $315,000 | -46.7% | 4,038 | -29.6% | 0.02% | -51.5% |
| Q2 2019 | $591,000 | +32.5% | 5,738 | -39.4% | 0.03% | +65.0% |
| Q3 2018 | $446,000 | -68.2% | 9,472 | -66.7% | 0.02% | -64.9% |
| Q2 2018 | $1,403,000 | +2092.2% | 28,468 | +140.2% | 0.06% | +1800.0% |
| Q2 2016 | $64,000 | -70.6% | 11,852 | +8.4% | 0.00% | -72.7% |
| Q2 2014 | $218,000 | – | 10,931 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |